-
CDC, U.S. Public Health Service advise use of daily HIV-prevention pill among at-risk populations
ATLANTA — The Centers for Disease Control and Prevention on Wednesday released guidance advising practitioners to offer an HIV prevention pill to healthy individuals who are at high-risk for an HIV infection, according to published reports.
The guidelines, issued in conjunction with the U.S. Public Health Service, involve the use of pre-exposure prophylaxis, a strategy in which at-risk individuals take a daily dose of an antiretroviral drug to reduce their risk of HIV infection.
-
Irrationality: Looking at nonadherence through the lens of behavioral economics
Call it the triumph of irrationality over self-interest.
Healthcare experts and pharmacy leaders have been grappling with the challenge of patient nonadherence for decades. They’ve spent countless hours trying to understand why patients often don’t act in their own therapeutic best interests, even when they know the health risks they incur by failing to take their medicines as prescribed.